• Fractional CEO/COO leadership and strategic, operational, fund raising and M&A consulting for start up/early-stage medical tech / device companies. High G2M, Scaling and product development focus.

• Full global P&L responsibility for industrial technology firm that manufactured precision engineered sensors and solutions measuring pressure, temperature, Rheology and Viscosity for plastics (injection molding, extrusion, OEM /B2B, recycling, etc.), Oil & Gas, aerospace, automotive, healthcare and food.
• Envisioned and led a comprehensive global growth and operational turnaround via a robust strategic plan and deployment, consolidating the global footprint to yield a $3.5M annualized EBITDA increase and achieving 38% business growth in 2 years, 8%+ EBITDA CAGR, and 27% GM improvement. Led M&A process to sell major ownership to CDR (PE) in 11/2023. Led transformation from sensor provider to precision engineering smart platform focus enabling broader organic and acquired value propositions.
• Improved operational efficiency by implementing lean principles, KPIs, analytics, and load optimization, resulting in 7 to 27% GM improvement and successful site consolidation within 5 months

• P&L responsibility for an international private mid cap MedTech infection prevention business.
• Achieved 35%+ business growth, surpassing profit targets and reduced team turnover from 42% to 11 %, implementing a 5-year strategic plan poised for over 100% growth. Optimzed Sales comp plans to drive growth, market and account share and exceeded target KPIs. (Medical Device)
• Acquired, integrated Tru-D ($100K+/Unit Med Tech) and realized 300% growth first post-acquisition year. Optimized the commercial strategy and structure, gained market and key account wallet share.
• Strengthen relationships with military, distributors, GPOs, and IDNs, accelerated e-commerce traction.
• Created business case and key presenter securing a $300M line of credit to finance capacity expansion.

• Global corporate marketing and communications for a large cap public clinical research organization.
• Transformed marketing, achieving a 35%+ increase in demand generation through digital capabilities.
• Increased demand generation, enabled 25% in new business and 20% in market share growth. Led creation of new Parexel and Parexel Biotech branding, resulting in a 15% increase in brand recognition.

• P&L, up / downstream marketing and product management for Ultrasound and Informatics businesses.
• Established Healthcare Informatics Services and Solutions global marketing structure, 5-year marketing strategy and multiyear operational plan. (Medical Device/ Technology / US Payer / In vivo med device)
• Conceptualized and executed a record breaking innovative G2M strategy for a major Ultrasound global product launch that achieved 1150 Order intake, 815 units sold ($100-$350K/unit), 77M€, 70%+ GM and 8-10% price premium in 4 months. Gained 2% incremental share (23% global share), no margin erosion.
• Partnered with R&D, Clinical /Regulatory affairs to achieve FDA / EU approvals & insurance coverage.

• Up and downstream marketing, P&L and product management for arthroscopic portfolio.
• Achieved 10% revenue CAGR and 17% GM CAGR for 7 franchises. and formulated a detailed long term profitability improvement strategy, including a 30% SKU reduction and 5%-40% COGS reduction.
• Gained market share, grew margins by 10% and increased vitality by 36%.

• Global up and downstream marketing, product management, and P&L responsibility for CRDM Pacemaker and Structural Heart Disease Businesses (SHD). NA P&L responsibility SHD service.
• Grew $300M portfolio to $800M with leadership position in 6 key segments. Completed 3 acquisitions.
• Achieved 16% and 11
● annual growth, transformed 200+ member commercial team to high performance account focus. Exceeded 100-member service team performance targets.
• Architected innovative G2M strategy to enable highly successful transcatheter heart value technologies.
• Partnered with R&D, Clinical /Regulatory affairs to achieve FDA / EU approvals & insurance coverage.

CRDM-Cardiovascular Rhythm Diagnostic Management(med tech/ device)
• Led global marketing team to achieve a peak market share of 55% in pacemakers.
• Led product managers, exceeded launch goals with 65% premium positioning and positive ASP uplift driving FY07 product responsibility to $931
● US and $1.859B worldwide with 3% and 5% growth.
• Partnered with R&D, Clinical /Regulatory affairs to achieve FDA / EU approvals & insurance coverage.

• Product development leadership. Global and expatriate marketing, product management and P&L responsibility. Corporate controlling / analyst for NA Bayer businesses.
• Led product development team, worked with IDEO to develop 8 product concepts, 3 commercialized.
• Led a €505 million glucose meter (medical device) portfolio, achieved 11
● revenue growth.
• Achieved 7% growth plan, saving over $10 million and increased GM by $12 million.
• Led a €28 Million business, achieved 31
● sales and 20% increase in market share with DEX2 launch.
• Completed corporate planning, controlling and strategic analysis for all Bayer North American business.
• Partnered with R&D, Clinical /Regulatory affairs to achieve FDA / EU approvals & insurance coverage.

J&J, Ortho Clinical Diagnostics-Hemostasis IV Diagnostics Raritan, New Jersey
• Global Product management, upstream marketing and P&L responsibility
• Commercialized new recombinant technology $100M in-vitro diagnostic. Led $50M P&L in a $300M Capital equipment alliance.